C200-1119 Screening compound: 3-(3,5-dimethoxyphenyl)-N-[2-(4-methylphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide

C200-1119 Screening compound: 3-(3,5-dimethoxyphenyl)-N-[2-(4-methylphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide
C200-1119 Screening compound: 3-(3,5-dimethoxyphenyl)-N-[2-(4-methylphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C200-1119
3-(3,5-dimethoxyphenyl)-N-[2-(4-methylphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C200-1119

Molecular Formula

C26H25N3O5 (C26 H25 N3 O5)

Compound Name

3-(3,5-dimethoxyphenyl)-N-[2-(4-methylphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazoline-7-carboxamide

IUPAC name

3-(35-dimethoxyphenyl)-N-[2-(4-methylphenyl)ethyl]-24-dioxo-1234-tetrahydroquinazoline-7-carboxamide

SMILES

Cc1ccc(CCNC(c(cc2)cc(NC(N3c4cc(OC)cc(OC)c4)=O)c2C3=O)=O)cc1

InChI

InChI=1S/C26H25N3O5/c1-16-4-6-17(7-5-16)10-11-27-24(30)18-8-9-22-23(12-18)28-26(32)29(25(22)31)19-13-20(33-2)15-21(14-19)34-3/h4-9,12-15H,10-11H2,1-3H3,(H,27,30)(H,28,32)

InChI Key

LCJNJRLELKYYOD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14725902

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

459.5

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.717

Distribution Coefficient, logD

3.714

Water Solubility, LogSw

-3.96

Polar Surface Area

79.211

Acid Dissociation Constant (pKa)

9.64

Base Dissociation Constant (pKb)

-2.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.20

C200-1119 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Human Proteases Annotated Library (2868 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with C200-1119 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C200-1119?
Check Price and Availability of C200-1119, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C200-1119 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C200-1119
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C200-1119
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C200-1119 available by request